logo
Select company
Select metric
0.05Cash Ratio
VS
Market
9
Sector
4
Industry
2
History
-
$ 2.58Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 476K0.05$ 10.39M
3/31/2025$ 898K0.09$ 9.77M
12/31/2024$ 1.7M0.18$ 9.54M
9/30/2024$ 915K0.09$ 10.1M
6/30/2024$ 3.55M0.4$ 8.84M
3/31/2024$ 3.29M0.33$ 9.88M
12/31/2023$ 5.44M0.63$ 8.65M
9/30/2023$ 15.26M3.24$ 4.72M
6/30/2023$ 21.04M7.29$ 2.88M
3/31/2023$ 23.39M12.74$ 1.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) Cash Ratio stands at 48.42.
  • Over the past 5 years, AIM IMMUNOTECH INC's average Cash Ratio has been 19.76.
  • The median Cash Ratio for AIM IMMUNOTECH INC during this period was 11.51
  • AIM IMMUNOTECH INC reached its highest Cash Ratio over the past 5 years at 50.28.
  • The lowest Cash Ratio recorded by AIM IMMUNOTECH INC in the same timeframe 0.05

AIM IMMUNOTECH INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
SILO : SILO PHARMA INC 4.13VIVS : VIVOSIM LABS INC 4.29HCWB : HCW BIOLOGICS INC 0.09CDIO : CARDIO DIAGNOSTICS HOLDINGS INC 21.59IBO : IMPACT BIOMEDICAL INC 0.03PMCB : PHARMACYTE BIOTECH INC 12.42APVO : APTEVO THERAPEUTICS INC 1.92ACXP : ACURX PHARMACEUTICALS INC 2.34PALI : PALISADE BIO INC 1.37GNPX : GENPREX INC 0.55

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for AIM IMMUNOTECH INC is calculated as follows: CashnEq [ $ 38.5M ] / LiabilitesC [ $ 795K ]
(=) Cash Ratio [ 48.42 ]

AIM - Cash Ratio, Last 5 years

0.05

Minimum

Jun 30, 2025

50.28

Maximum

Mar 31, 2021

19.76

Average

11.51

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63